Note 9 - Accrued Expenses and Other Current Liabilities

6 Months Ended

Jun. 30, 2026

Notes to Financial Statements

Accounts Payable and Accrued Liabilities Disclosure [Text Block]

9.	Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following:

		June 30,				December 31,
		2026				2025
Compensation and related expenses		$	7,536			$	8,658
Stock-based compensation			3,940				2,448
Operating lease liability – current			1,935				2,052
Professional fees			1,606				1,800
Clinical trial costs			446				441
Deferred revenue			122				-
Other			326				468
Total		$	15,911			$	15,867